$NVEC
NVE CORP /NEW/ Stock $nvec

$nvec Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000137647423000368 Filed on July 19, 2023

Income Statement

Concept	2023 Q3	2023 Q2	2022 Q2
Revenue	$7.133M	$8.831M	$7.336M
YoY Change	-33.44%	20.38%	2.56%
Cost Of Revenue	$1.600M	$2.080M	$1.652M
YoY Change	-33.42%	25.9%	-6.65%
Gross Profit	$5.533M	$6.752M	$5.685M
YoY Change	-33.45%	18.77%	5.59%
Gross Profit Margin	77.57%	76.45%	77.48%
Selling, General & Admin	$230.0K	$687.6K	$371.3K
YoY Change	-47.2%	85.17%	-20.42%
% of Gross Profit	4.16%	10.18%	6.53%
Research & Development	$683.2K	$696.0K	$601.9K
YoY Change	1.97%	15.63%	-25.52%
% of Gross Profit	12.35%	10.31%	10.59%
Depreciation & Amortization	$50.00K	$59.46K	$87.62K
YoY Change	-29.8%	-32.14%	-37.6%
% of Gross Profit	0.9%	0.88%	1.54%
Operating Expenses	$914.1K	$1.384M	$973.2K
YoY Change	-17.32%	42.16%	-23.65%
Operating Profit	$4.619M	$5.368M	$4.711M
YoY Change	-35.93%	13.94%	14.66%
Interest Expense	$510.0K	$436.5K	$283.1K
YoY Change	45.14%	54.22%	-2.3%
% of Operating Profit	11.04%	8.13%	6.01%
Other Income/Expense, Net
YoY Change
Pretax Income	$5.131M	$5.805M	$4.994M
YoY Change	-32.13%	16.23%	13.55%
Income Tax	$407.9K	$1.401M	$854.3K
% Of Pretax Income	7.95%	24.14%	17.1%
Net Earnings	$4.724M	$4.404M	$4.140M
YoY Change	-22.44%	6.37%	15.66%
Net Earnings / Revenue	66.22%	49.86%	56.43%
Basic Earnings Per Share	$0.98	$0.91	$0.86
Diluted Earnings Per Share	$0.98	$0.91	$0.86
COMMON SHARES
Basic Shares Outstanding	4.833M shares	4.831M shares	4.831M
Diluted Shares Outstanding	4.841M shares	4.841M shares	4.831M

Balance Sheet

Concept	2023 Q3	2023 Q2	2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$14.20M	$13.61M	$28.19M
YoY Change	2.08%	-51.7%	8.7%
Cash & Equivalents	$6.953M	$1.440M	$13.30M
Short-Term Investments	$7.200M	$12.17M	$14.89M
Other Short-Term Assets	$1.100M	$707.2K	$722.0K
YoY Change	83.06%	-2.05%	9.68%
Inventory	$6.968M	$6.292M	$5.544M
Prepaid Expenses	$1.065M	$707.2K
Receivables	$2.916M	$5.397M	$3.513M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$25.13M	$26.01M	$37.97M
YoY Change	-3.98%	-31.49%	13.07%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.207M	$1.665M	$483.5K
YoY Change	174.9%	244.32%	61.5%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$39.60M	$39.72M	$25.52M
YoY Change	0.22%	55.65%	-31.89%
Other Assets	$1.400M	$724.8K	$578.3K
YoY Change	56.59%	25.33%	468.85%
Total Long-Term Assets	$42.58M	$42.11M	$27.11M
YoY Change	3.01%	55.34%	-29.63%
TOTAL ASSETS
Total Short-Term Assets	$25.13M	$26.01M	$37.97M
Total Long-Term Assets	$42.58M	$42.11M	$27.11M
Total Assets	$67.71M	$68.12M	$65.07M
YoY Change	0.3%	4.68%	-9.75%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$244.2K	$159.2K	$295.4K
YoY Change	-38.83%	-46.13%	-17.79%
Accrued Expenses	$539.5K	$1.112M	$824.4K
YoY Change	-82.13%	34.93%	2.75%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$961.3K	$1.271M	$1.120M
YoY Change	-71.88%	13.54%	-43.9%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$300.0K	$301.9K	$411.4K
YoY Change	-19.99%	-26.63%	-25.04%
Total Long-Term Liabilities	$300.0K	$301.9K	$411.4K
YoY Change	-19.99%	-26.63%	-25.04%
TOTAL LIABILITIES
Total Short-Term Liabilities	$961.3K	$1.271M	$1.120M
Total Long-Term Liabilities	$300.0K	$301.9K	$411.4K
Total Liabilities	$1.222M	$1.573M	$1.531M
YoY Change	-67.79%	2.75%	-39.84%
SHAREHOLDERS EQUITY
Retained Earnings	$48.41M	$48.52M	$44.89M
YoY Change	4.91%	8.1%	-8.67%
Common Stock	$48.33K	$48.33K	$19.31M
YoY Change	-99.75%	-99.75%	-0.42%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$66.49M	$66.55M	$63.54M
YoY Change
Total Liabilities & Shareholders Equity	$67.71M	$68.12M	$65.07M
YoY Change	0.3%	4.68%	-9.75%

Cashflow Statement

Concept	2023 Q3	2023 Q2	2022 Q2
OPERATING ACTIVITIES
Net Income	$4.724M	$4.404M	$4.140M
YoY Change	-22.44%	6.37%	15.66%
Depreciation, Depletion And Amortization	$50.00K	$59.46K	$87.62K
YoY Change	-29.8%	-32.14%	-37.6%
Cash From Operating Activities	$5.350M	$5.025M	$3.331M
YoY Change	-11.13%	50.86%	0.93%
INVESTING ACTIVITIES
Capital Expenditures	$20.00K	$4.130K	$24.50K
YoY Change		-83.14%	-4.59%
Acquisitions
YoY Change
Other Investing Activities	$5.000M	-$537.8K	$4.374M
YoY Change	-145.85%	-112.3%
Cash From Investing Activities	$4.990M	-$542.0K	$4.349M
YoY Change	-145.76%	-112.46%	-17037.72%
FINANCING ACTIVITIES
Cash Dividend Paid		$4.831M	$4.831M
YoY Change		0.0%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-4.840M	-4.713M	-$4.831M
YoY Change	0.19%	-2.43%	-0.05%
NET CHANGE
Cash From Operating Activities	5.350M	5.025M	$3.331M
Cash From Investing Activities	4.990M	-542.0K	$4.349M
Cash From Financing Activities	-4.840M	-4.713M	-$4.831M
Net Change In Cash	5.500M	-230.0K	$2.850M
YoY Change	-156.61%	-108.07%	-282.85%
FREE CASH FLOW
Cash From Operating Activities	$5.350M	$5.025M	$3.331M
Capital Expenditures	$20.00K	$4.130K	$24.50K
Free Cash Flow	$5.330M	$5.021M	$3.307M
YoY Change	-11.46%	51.85%	0.97%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q2	dei	Document Type DocumentType	10-Q
CY2023Q2	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q2	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
CY2023Q2	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q2	dei	Entity File Number EntityFileNumber	000-12196
CY2023Q2	dei	Entity Registrant Name EntityRegistrantName	NVE CORP
CY2023Q2	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MN
CY2023Q2	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	41-1424202
CY2023Q2	dei	Entity Address Address Line1 EntityAddressAddressLine1	1409 Valley View Road
CY2023Q2	dei	Entity Address City Or Town EntityAddressCityOrTown	Eden Prairie
CY2023Q2	dei	Entity Address State Or Province EntityAddressStateOrProvince	MN
CY2023Q2	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	55344
CY2023Q2	dei	Entity Address Address Description EntityAddressAddressDescription	Address of principal executive offices
CY2023Q2	dei	City Area Code CityAreaCode	952
CY2023Q2	dei	Local Phone Number LocalPhoneNumber	829-9217
CY2023Q2	dei	Phone Fax Number Description PhoneFaxNumberDescription	Registrant’s telephone number, including area code
CY2023Q2	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q2	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q2	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q2	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q2	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q2	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Security12b Title Security12bTitle	Common Stock, $0.01 par value
CY2023Q2	dei	Trading Symbol TradingSymbol	NVEC
CY2023Q2	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q2	dei	Entity Listing Par Value Per Share EntityListingParValuePerShare	0.01
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	4833401	shares
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1439933	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1669896	usd
CY2023Q2	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	12300315	usd
CY2023Q1	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	15696135	usd
CY2023Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	12173737	usd
CY2023Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	15513095	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	227440	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	15000	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5397032	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6523344	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	6292162	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	6417010	usd
CY2023Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	707175	usd
CY2023Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	663459	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	26010039	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	30786804	usd
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	10488496	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	10484365	usd
CY2023Q2	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	1956309	usd
CY2023Q1	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	1956309	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	11172258	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	11095236	usd
CY2023Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	1272547	usd
CY2023Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	1345438	usd
CY2023Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	724773	usd
CY2023Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	572038	usd
CY2023Q2	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	41447065	usd
CY2023Q1	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	37495846	usd
CY2023Q2	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	39719369	usd
CY2023Q1	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	36125047	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	392370	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	695992	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	601918	usd
CY2023Q2	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	475115	usd
CY2022Q2	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	371320	usd
CY2023Q2	us-gaap	Provision For Other Credit Losses ProvisionForOtherCreditLosses	212440	usd
CY2022Q2	us-gaap	Provision For Other Credit Losses ProvisionForOtherCreditLosses	0	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	1383547	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	973238	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	5368244	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	4711322	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	425843	usd
CY2023Q2	us-gaap	Assets Assets	68119098	usd
CY2023Q1	us-gaap	Assets Assets	69255170	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	159155	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	281712	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	935621	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1375250	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	176688	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	175798	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	1271464	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	1832760	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	301866	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	342908	usd
CY2023Q2	us-gaap	Liabilities Liabilities	1573330	usd
CY2023Q1	us-gaap	Liabilities Liabilities	2175668	usd
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	6000000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	6000000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4833401	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4833401	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4830826	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4830826	shares
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	48334	usd
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	48308	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	19423479	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	19295442	usd
CY2023Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1448559	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1213858	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	48522514	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	48949610	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	66545768	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	67079502	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	68119098	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	69255170	usd
CY2023Q2	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	8700092	usd
CY2022Q2	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	7072961	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	131322	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	263446	usd
CY2023Q2	us-gaap	Revenues Revenues	8831414	usd
CY2022Q2	us-gaap	Revenues Revenues	7336407	usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue	2079623	usd
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue	1651847	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	6751791	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	5684560	usd
CY2023Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	436526	usd
CY2022Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	283059	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	5804770	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	4994381	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1401040	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	854265	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	4403730	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	4140116	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.91
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.86
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.91
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.86
CY2023Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.00
CY2022Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.00
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4832166	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4830826	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4840571	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4830871	shares
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	4403730	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	4140116	usd
CY2023Q2	fil	Unrealized Loss From Marketable Securities Net Of Tax1 UnrealizedLossFromMarketableSecuritiesNetOfTax1	-234701	usd
CY2022Q2	fil	Unrealized Loss From Marketable Securities Net Of Tax1 UnrealizedLossFromMarketableSecuritiesNetOfTax1	-338553	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	4169029	usd
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	3801563	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	67079502	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	117527	usd
CY2023Q2	fil	Unrealized Loss From Marketable Securities Net Of Tax1 UnrealizedLossFromMarketableSecuritiesNetOfTax1	-234701	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	4403730	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	4169029	usd
CY2023Q2	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	10536	usd
CY2023Q2	us-gaap	Dividends Cash DividendsCash	4830826	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	66545768	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	64565129	usd
CY2022Q2	fil	Unrealized Loss From Marketable Securities Net Of Tax1 UnrealizedLossFromMarketableSecuritiesNetOfTax1	-338553	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	4140116	usd
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	3801563	usd
CY2022Q2	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	7134	usd
CY2022Q2	us-gaap	Dividends Cash DividendsCash	4830826	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	63543000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	4403730	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	4140116	usd
CY2023Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	59457	usd
CY2022Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	87621	usd
CY2023Q2	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	212440	usd
CY2022Q2	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	0	usd
CY2023Q2	us-gaap	Employee Benefits And Share Based Compensation Noncash EmployeeBenefitsAndShareBasedCompensationNoncash	10536	usd
CY2022Q2	us-gaap	Employee Benefits And Share Based Compensation Noncash EmployeeBenefitsAndShareBasedCompensationNoncash	7134	usd
CY2023Q2	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-87000	usd
CY2022Q2	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	1	usd
CY2023Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-913872	usd
CY2022Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1191613	usd
CY2023Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-124848	usd
CY2022Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	455402	usd
CY2023Q2	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	10243	usd
CY2022Q2	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	268772	usd
CY2023Q2	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-602338	usd
CY2022Q2	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1371168	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	5025302	usd
CY2022Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3331143	usd
CY2023Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4131	usd
CY2022Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	24500	usd
CY2023Q2	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	3937835	usd
CY2022Q2	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	4976063	usd
CY2023Q2	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	3400000	usd
CY2022Q2	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	9250000	usd
CY2023Q2	us-gaap	Proceeds From Contribution In Aid Of Construction ProceedsFromContributionInAidOfConstruction	0	usd
CY2022Q2	us-gaap	Proceeds From Contribution In Aid Of Construction ProceedsFromContributionInAidOfConstruction	100000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-541966	usd
CY2022Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	4349437	usd
CY2023Q2	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	117527	usd
CY2022Q2	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
CY2023Q2	us-gaap	Payments Of Dividends PaymentsOfDividends	4830826	usd
CY2022Q2	us-gaap	Payments Of Dividends PaymentsOfDividends	4830826	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-4713299	usd
CY2022Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-4830826	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-229963	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	2849754	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1669896	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10449510	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1439933	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13299264	usd
CY2023Q2	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1195542	usd
CY2022Q2	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1275629	usd
CY2023Q2	us-gaap	Nature Of Operations NatureOfOperations	<p style="font:10pt Times New Roman;margin:0"><b>NOTE 1. DESCRIPTION OF BUSINESS</b></p> <p style="font:10pt Times New Roman;margin:0;text-indent:9pt">We develop and sell devices that use spintronics, a nanotechnology that relies on electron spin rather than electron charge to acquire, store, and transmit information. </p>
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4832166	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4830826	shares
CY2023Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	8405	shares
CY2022Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	45	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4840571	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4830871	shares
CY2023Q2	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest DebtSecuritiesAvailableForSaleExcludingAccruedInterest	418336	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest DebtSecuritiesAvailableForSaleExcludingAccruedInterest	425372	usd
CY2023Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	53187406	usd
CY2023Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	53187406	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	52544283	usd
CY2023Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	55041680	usd
CY2023Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	1	usd
CY2023Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	1854275	usd
CY2023Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	53187406	usd
CY2023Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	54098122	usd
CY2023Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	1007	usd
CY2023Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	1554846	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	52544283	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	227440	usd
CY2023Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	36594686	usd
CY2023Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	934611	usd
CY2023Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	15298420	usd
CY2023Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	919664	usd
CY2023Q2	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	51893106	usd
CY2023Q2	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	1854275	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	37084628	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	590967	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	13294817	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	963879	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	50379445	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	1554846	usd
CY2023Q2	fil	Unrealized Loss From Marketable Securities UnrealizedLossFromMarketableSecurities	-300437	usd
CY2022Q2	fil	Unrealized Loss From Marketable Securities UnrealizedLossFromMarketableSecurities	-433376	usd
CY2023Q2	fil	Tax Effects TaxEffects	65736	usd
CY2022Q2	fil	Tax Effects TaxEffects	94823	usd
CY2023Q2	fil	Unrealized Loss From Marketable Securities Net Of Tax UnrealizedLossFromMarketableSecuritiesNetOfTax	-234701	usd
CY2022Q2	fil	Unrealized Loss From Marketable Securities Net Of Tax UnrealizedLossFromMarketableSecuritiesNetOfTax	-338553	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	15000	usd
CY2023Q2	us-gaap	Allowance For Loan And Lease Losses Period Increase Decrease AllowanceForLoanAndLeaseLossesPeriodIncreaseDecrease	212440	usd
CY2023Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	1741172	usd
CY2023Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	1601962	usd
CY2023Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	2914014	usd
CY2023Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	3781894	usd
CY2023Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1636976	usd
CY2023Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1033154	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	6292162	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	6417010	usd
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10536	usd
CY2022Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7134	usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Method Used ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsMethodUsed	Black-Scholes-Merton standard option-pricing model
CY2023Q2	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	453591	usd
CY2023Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023Q2	us-gaap	Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit	0	usd
CY2023Q2	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Accrued UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued	0	usd
CY2023Q2	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	1	pure
CY2023Q2	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	0.03	pure
CY2023Q2	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	27078	usd
CY2023Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	37754	usd
CY2023Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	44433	usd
CY2023Q2	us-gaap	Lessee Operating Lease Remaining Lease Term LesseeOperatingLeaseRemainingLeaseTerm	P33M
CY2023Q2	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.035	pure
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	134207	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	182271	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	184995	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	501473	usd
CY2023Q2	us-gaap	Unrecorded Unconditional Purchase Obligation Imputed Interest UnrecordedUnconditionalPurchaseObligationImputedInterest	22919	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	478554	usd
CY2009Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	2500000	usd
CY2023Q2	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	3520369	usd
CY2023Q2	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	0	shares
CY2022Q2	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	28426	usd
CY2023Q3	us-gaap	Subsequent Events Date SubsequentEventsDate	2023-07-19
CY2023Q3	us-gaap	Subsequent Event Description SubsequentEventDescription	we announced that our Board of Directors had declared a quarterly cash dividend
CY2023Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.00
CY2023Q3	us-gaap	Dividend Payable Date To Be Paid Day Month And Year DividendPayableDateToBePaidDayMonthAndYear	2023-08-31
CY2023Q3	us-gaap	Dividends Payable Date Of Record Day Month And Year DividendsPayableDateOfRecordDayMonthAndYear	2023-07-31

Files In Submission

Name	View Source	Status
0001376474-23-000368-index-headers.html	Edgar Link	pending
0001376474-23-000368-index.html	Edgar Link	pending
0001376474-23-000368.txt	Edgar Link	pending
0001376474-23-000368-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nve10q_1.jpg	Edgar Link	pending
nvec-20230630.htm	Edgar Link	pending
nvec-20230630.xsd	Edgar Link	pending
nve_ex31z1.htm	Edgar Link	pending
nve_ex31z2.htm	Edgar Link	pending
nve_ex32.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
nvec-20230630_cal.xml	Edgar Link	unprocessable
nvec-20230630_def.xml	Edgar Link	unprocessable
nvec-20230630_lab.xml	Edgar Link	unprocessable
nvec-20230630_pre.xml	Edgar Link	unprocessable
nvec-20230630_htm.xml	Edgar Link	completed
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NVEC
NVE CORP /NEW/ Stock $nvec

2023 Q3 Form 10-Q Financial Statement

#000137647423000368 Filed on July 19, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NVEC NVE CORP /NEW/ Stock $nvec

2023 Q3 Form 10-Q Financial Statement

#000137647423000368 Filed on July 19, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NVEC
NVE CORP /NEW/ Stock $nvec